PDS Biotechnology(PDSB)

2.785 -0.215 -7.1667%

今开:2.97昨收:3.0
最高:2.9789 最低:2.7
涨停价:0.0跌停价:0.0
总市值:1.02151781E8

PDS Biotechnology的热门讨论

产业链观察03-27 20:59

#药闻简讯# $PDS Biotechnology(PDSB)$ 放弃之前承诺的 PDS0101-Keytruda 组合治疗 HPV 驱动的头颈癌的 Ph3 研究查看全文

当期报告

PDS Biotechnology(PDSB)03-27 19:35

$PDS Biotechnology(PDSB)$ 8-K Current report, items 2.02, 8.01, and 9.01 Accession Number: 0001140361-24-015456  Act: 34  Size: 4 MB 网页链接查看全文

当期报告

PDS Biotechnology(PDSB)05-09 04:15

$PDS Biotechnology(PDSB)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001140361-24-024934  Act: 34  Size: 6 MB 网页链接查看全文

当期报告

PDS Biotechnology(PDSB)05-10 18:15

$PDS Biotechnology(PDSB)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001140361-24-025256  Act: 34  Size: 199 KB 网页链接查看全文

当期报告

PDS Biotechnology(PDSB)05-15 20:05

$PDS Biotechnology(PDSB)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001140361-24-026107  Act: 34  Size: 272 KB 网页链接查看全文

当期报告

PDS Biotechnology(PDSB)06-12 20:15

$PDS Biotechnology(PDSB)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001140361-24-029820  Act: 34  Size: 6 MB 网页链接查看全文

当期报告

PDS Biotechnology(PDSB)05-02 18:15

$PDS Biotechnology(PDSB)$ 8-K Current report, items 5.02, 8.01, and 9.01 Accession Number: 0001140361-24-023815  Act: 34  Size: 535 KB 网页链接查看全文

持股变动声明

PDS Biotechnology(PDSB)05-03 04:25

$PDS Biotechnology(PDSB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001140361-24-024002  Size: 5 KB 网页链接查看全文

股东委托书协议

PDS Biotechnology(PDSB)04-29 19:15

$PDS Biotechnology(PDSB)$ DEF 14A Other definitive proxy statements Accession Number: 0001140361-24-022685  Act: 34  Size: 2 MB 网页链接查看全文

其他

PDS Biotechnology(PDSB)04-19 04:25

$PDS Biotechnology(PDSB)$ PRE 14A Other preliminary proxy statements Accession Number: 0001140361-24-020516  Act: 34  Size: 2 MB 网页链接查看全文

1 2

PDS Biotechnology的最新讨论

产业链观察03-27 20:59

#药闻简讯# $PDS Biotechnology(PDSB)$ 放弃之前承诺的 PDS0101-Keytruda 组合治疗 HPV 驱动的头颈癌的 Ph3 研究查看全文

产业链观察2023-10-03 21:23

#药闻简讯# $PDS Biotechnology(PDSB)$ 宣布PDS0101联合KEYTRUDA治疗免疫检查点抑制剂无效头颈癌患者的24个月中期生存率为74%
网页链接查看全文

牛唐2023-08-17 21:29

医药板块速评(2023.08.16)
1、华尔街投行评选的医药公司潜在并购标的有哪些?
2、$PDS Biotechnology(PDSB)、$Abeona Therapeutics(ABEO)等多家医药股走势强势,是否有配置机会?
3、$台积电(TSM)$$波士顿科学(BSX)$$Unity(U)$ 、$联合包裹(UPS)、$摩根大通(JPM)、$淡水河谷(V...查看全文

美股滚雪球2023-01-04 14:40

$PDS Biotechnology(PDSB)$ 与默克公司(OTCPK:MKGAF) 签署了肿瘤候选药物M9241的许可协议,该药物将以PDS0301的名称加入在研管线。
根据协议,PDSB将从默克公司获得M9241的独家许可,并负责M9241的未来开发、商业化和制造。
默克公司将获得500万美元的预付现金,并将有权获得高达1100万美...查看全文

chuminhua2023-01-04 10:52

1月3日,德国默克 (Merck KGaA) 签署了一项协议,授予 PDS Biotechnology 靶向 IL-12 融合蛋白 M9241 的全球独家许可,交易额高达 1.21 亿美元。 PDS Biotech 在声明中表示,该协议通过临床阶段资产加强其免疫肿瘤产品组合,该资产现已更名为 PDS0301,与其 Versamune T 细胞激活平台“协同”。查看全文

SeekingBiotech2023-01-03 22:57

$PDS Biotechnology(PDSB)$
PDSB Announces Exclusive Global License Agreement for Investigational IL-12 Tumor-Targeted Cytokine from Merck KGaA。引进德国🇩🇪默克白介素12,但是股票大跌。#细胞因子#查看全文

产业链观察2023-01-03 20:51

#药闻简讯# $PDS Biotechnology(PDSB)$ 宣布与默克公司签订调查性IL-12肿瘤靶向细胞因子的全球独家许可协议查看全文

mr_miumiu2021-07-01 00:37

$PDS Biotechnology(PDSB)$ 怂了,卖早了[拜托]查看全文

Dreamland20202021-06-20 14:32

$PDS Biotechnology(PDSB)$ 前两天增发消息出来后大跌,本来想等再跌一跌补仓的。结果失算了,有点遗憾查看全文

火线牛起来2021-06-09 23:37

$微美全息(WIMI)$ $Silvergate资本(SI)$ $PDS Biotechnology(PDSB)$ 和你们说了,不要怂,坚持持有,机遇迟早到的[鼓鼓掌]查看全文

1 2 3 4

PDS Biotechnology的公告

$PDS Biotechnology(PDSB)$ 8-K - Current report Filed: 2019-04-12 AccNo: 0001140361-19-007015 Size: 20 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers 网页链接

$PDS Biotechnology(PDSB)$ 8-K - Current report Filed: 2019-04-08 AccNo: 0001140361-19-006714 Size: 56 KBItem 4.01: Changes in Registrant's Certifying AccountantItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: C...

$PDS Biotechnology(PDSB)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2019-03-28 AccNo: 0001144204-19-016355 Size: 133 KB 网页链接

$PDS Biotechnology(PDSB)$ 8-K - Current report Filed: 2019-03-27 AccNo: 0001140361-19-005750 Size: 21 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers 网页链接

$PDS Biotechnology(PDSB)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2019-03-25 AccNo: 0001193125-19-085311 Size: 208 KB 网页链接

$PDS Biotechnology(PDSB)$ 8-K - Current report Filed: 2019-03-15 AccNo: 0001140361-19-005051 Size: 35 KBItem 5.07: Submission of Matters to a Vote of Security Holders 网页链接

$PDS Biotechnology(PDSB)$ 8-K - Current report Filed: 2019-03-18 AccNo: 0001140361-19-005071 Size: 103 KBItem 2.01: Completion of Acquisition or Disposition of AssetsItem 5.01: Changes in Control of RegistrantItem 5.02: Departure of Directors or Certain Officers; Election of ...

$PDS BIOTECHNOLOGY CORPORATION(PDSB)$ 8-K - Current report Filed: 2019-03-15 AccNo: 0001140361-19-005051 Size: 35 KBItem 5.07: Submission of Matters to a Vote of Security Holders 网页链接

$PDS BIOTECHNOLOGY CORPORATION(PDSB)$ 8-K - Current report Filed: 2019-03-18 AccNo: 0001140361-19-005071 Size: 103 KBItem 2.01: Completion of Acquisition or Disposition of AssetsItem 5.01: Changes in Control of RegistrantItem 5.02: Departure of Directors or Certain Officers; ...

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32